Intervention to Reduce Injection Drug Use

Not Applicable

Completed

• Conditions: Substance Abuse
• Interventions: Behavioral: Strengths-based case management; Behavioral: Case management plus facilitated treatment alliance

• Registration Number: NCT00786630
• Lead Sponsor: University of Colorado, Denver

Brief Summary

This is a five-year prospective randomized trial comparing two intervention conditions designed to facilitate substance abuse treatment entry and enhance retention in order to reduce the behaviors associated with HIV and HCV risk among injection drug users (IDUs) and to improve client overall functioning. The overall goal of this project is to compare strengths-based case-management (CM) to an enhanced version of CM that uses case managers to facilitate a therapeutic alliance (CM/FTA) among out-of-treatment IDUs in Denver.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-11
• Study First Submitted: 2008-11-04
• Study First Submitted QC: 2008-11-05
• Study First Posted: 2008-11-06
• Primary Completion: 2012-12
• Study Completion: 2013-02
• Status Verified: 2014-12
• Last Update Submitted: 2014-12-19
• Last Update Posted: 2014-12-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 726

Inclusion Criteria

• opiate injection at least 3 times a week during the last 6-months
• 18 years of age or older
• no drug abuse treatment in the 30-days prior to the interview
• not transient
• no known reason (e.g. pending jail time) why they will not be available for follow-up interviews
• not involved in Project Safe research activities in the previous 12 months
• willing to meet with an Addiction Research and Treatment Services (methadone clinic) counselor
• eligible to be treated at ARTS

Read More

Exclusion Criteria

• too intoxicated or impaired mentally to voluntarily consent to participate in the project and/or respond to the interview

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Case Management	Strengths-based case management	-
Facilitated Treatment Alliance	Case management plus facilitated treatment alliance	-

Primary Outcome Measures

Name	Time	Method
Treatment entry and retention	Baseline, 6 months after baseline, 12 months after baseline

Secondary Outcome Measures

Name	Time	Method
Drug injection and HIV/HCV risk behaviors	Baseline, 6 months after baseline, 12 months after baseline

Trial Locations

Locations (1)

Project Safe; 🇺🇸 Denver, Colorado, United States